Contineum Therapeutics, Inc. (CTNM)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch CTNM
See up to 3 months of CTNM. The 7-day demo opens the 1M and 3M ranges and puts CTNM on your watchlist.
Start 7-day demoLatest CTNM insider trades
About Contineum Therapeutics, Inc. (CTNM)
The SEC lists Contineum Therapeutics, Inc. under CIK 0001855175, in pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
CTNM Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 2 | 5,000 | $81K |
| Option exercise | 4 | 10,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
CTNM insider transactions (Form 4)
7832 Form 4 filings on record, the earliest from Nov 20, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Carmine N. Stengone - Officer | Option exercise | Class A Common Stock | 2,500 | $1.01 | $3K | |
| Carmine N. Stengone - Officer | Open-market sale | Class A Common Stock | 2,500 | $16.46 footnote F2 | $41K | |
| Carmine N. Stengone - Officer | Option exercise | Stock Option (right to buy) | 2,500 | $0.00 | - | |
| ||||||
| Carmine N. Stengone - Officer | Option exercise | Class A Common Stock | 2,500 | $1.01 | $3K | |
| Carmine N. Stengone - Officer | Open-market sale | Class A Common Stock | 2,500 | $16.01 footnote F2 | $40K | |
| Carmine N. Stengone - Officer | Option exercise | Stock Option (right to buy) | 2,500 | $0.00 | - | |
| ||||||
| Daniel S. Lorrain - Officer | Option exercise | Class A Common Stock | 1,015 | $1.01 | $1K | |
| Daniel S. Lorrain - Officer | Open-market sale | Class A Common Stock | 1,015 | $16.00 | $16K | |
| Daniel S. Lorrain - Officer | Option exercise | Class A Common Stock | 25 | $1.01 | $25 | |
| Daniel S. Lorrain - Officer | Open-market sale | Class A Common Stock | 25 | $16.00 | $400 | |
| Daniel S. Lorrain - Officer | Option exercise | Stock Option (right to buy) | 1,015 | $0.00 | - | |
| Daniel S. Lorrain - Officer | Option exercise | Stock Option (right to buy) | 25 | $0.00 | - | |
| Carmine N. Stengone - Officer | Option exercise | Class A Common Stock | 2,500 | $1.01 | $3K | |
| Carmine N. Stengone - Officer | Open-market sale | Class A Common Stock | 2,500 | $16.00 | $40K | |
| Carmine N. Stengone - Officer | Option exercise | Stock Option (right to buy) | 2,500 | $0.00 | - | |
| Daniel S. Lorrain - Officer | Open-market sale | Class A Common Stock | 5,852 | $15.67 footnote F3 | $92K | |
| Daniel S. Lorrain - Officer | Open-market sale | Class A Common Stock | 2,501 | $16.24 footnote F4 | $41K | |
| Daniel S. Lorrain - Officer | Option exercise | Stock Option (right to buy) | 28,826 | $0.00 | - | |
| Daniel S. Lorrain - Officer | Option exercise | Stock Option (right to buy) | 4,183 | $0.00 | - | |
| Daniel S. Lorrain - Officer | Option exercise | Class A Common Stock | 28,826 | $1.01 | $29K | |
| Daniel S. Lorrain - Officer | Open-market sale | Class A Common Stock | 28,826 | $16.04 footnote F2 | $462K | |
| Daniel S. Lorrain - Officer | Option exercise | Class A Common Stock | 4,183 | $1.01 | $4K | |
| ||||||
 Tim Watkins - Officer | Option exercise | Class A Common Stock | 10,833 | $4.50 | $49K | |
| Tim Watkins - Officer | Open-market sale | Class A Common Stock | 10,833 | $16.02 footnote F2 | $174K | |
| Tim Watkins - Officer | Option exercise | Stock Option (right to buy) | 10,833 | $0.00 | - | |
| ||||||
| Carmine N. Stengone - Officer | Option exercise | Class A Common Stock | 7,500 | $1.01 | $8K | |
| Carmine N. Stengone - Officer | Option exercise | Class A Common Stock | 2,500 | $1.26 | $3K | |
| Carmine N. Stengone - Officer | Open-market sale | Class A Common Stock | 10,000 | $16.01 footnote F2 | $160K | |
| Carmine N. Stengone - Officer | Option exercise | Stock Option (right to buy) | 7,500 | $0.00 | - | |
| Carmine N. Stengone - Officer | Option exercise | Stock Option (right to buy) | 2,500 | $0.00 | - | |
| ||||||
| Gines Diego Miralles - Director | Grant or award | Stock Option (right to buy) | 19,000 | $0.00 | - | |
| Lori Lyons-Williams - Director | Grant or award | Stock Option (right to buy) | 19,000 | $0.00 | - | |
| Olivia C. Ware - Director | Grant or award | Stock Option (right to buy) | 19,000 | $0.00 | - | |
| Evert B. Schimmelpennink - Director | Grant or award | Stock Option (right to buy) | 19,000 | $0.00 | - | |
 Troy A. Ignelzi - Director | Grant or award | Stock Option (right to buy) | 19,000 | $0.00 | - | |
| Todd R. Brady - Director | Grant or award | Stock Option (right to buy) | 19,000 | $0.00 | - | |
| Sarah Boyce - Director | Grant or award | Stock Option (right to buy) | 19,000 | $0.00 | - | |
| Daniel S. Lorrain - Officer | Open-market sale | Class A Common Stock | 4,170 | $13.16 footnote F2 | $55K | |
| ||||||
| Daniel S. Lorrain - Officer | Open-market sale | Class A Common Stock | 3,870 | $13.06 footnote F2 | $51K | |
| Daniel S. Lorrain - Officer | Open-market sale | Class A Common Stock | 300 | $13.84 footnote F3 | $4K | |
| ||||||
| Daniel S. Lorrain - Officer | Open-market sale | Class A Common Stock | 4,170 | $13.43 footnote F2 | $56K | |
| ||||||
| Daniel S. Lorrain - Officer | Open-market sale | Class A Common Stock | 4,170 | $15.01 footnote F2 | $63K | |
| ||||||
| Tim Watkins - Officer | Option exercise | Class A Common Stock | 3,611 | $4.50 | $16K | |
| Tim Watkins - Officer | Open-market sale | Class A Common Stock | 3,611 | $15.02 footnote F2 | $54K | |
| Tim Watkins - Officer | Option exercise | Stock Option (right to buy) | 3,611 | $0.00 | - | |
| ||||||
| Carmine N. Stengone - Officer | Option exercise | Class A Common Stock | 4,400 | $1.26 | $6K | |
| Carmine N. Stengone - Officer | Open-market sale | Class A Common Stock | 4,400 | $16.02 footnote F2 | $70K | |
| Carmine N. Stengone - Officer | Option exercise | Class A Common Stock | 2,700 | $1.26 | $3K | |
| Carmine N. Stengone - Officer | Open-market sale | Class A Common Stock | 2,700 | $16.02 footnote F3 | $43K | |
| Carmine N. Stengone - Officer | Option exercise | Stock Option (right to buy) | 4,400 | $0.00 | - | |
| Carmine N. Stengone - Officer | Option exercise | Stock Option (right to buy) | 2,700 | $0.00 | - | |
| ||||||
| Daniel S. Lorrain - Officer | Option exercise | Class A Common Stock | 4,300 | $1.01 | $4K | |
| Daniel S. Lorrain - Officer | Open-market sale | Class A Common Stock | 4,300 | $16.03 footnote F2 | $69K | |
| Daniel S. Lorrain - Officer | Option exercise | Stock Option (right to buy) | 4,300 | $0.00 | - | |
| Daniel S. Lorrain - Officer | Option exercise | Class A Common Stock | 3,824 | $1.01 | $4K | |
| Daniel S. Lorrain - Officer | Open-market sale | Class A Common Stock | 3,824 | $16.01 footnote F3 | $61K | |
| Daniel S. Lorrain - Officer | Option exercise | Stock Option (right to buy) | 3,824 | $0.00 | - | |
| ||||||
| Daniel S. Lorrain - Officer | Option exercise | Class A Common Stock | 100 | $1.01 | $101 | |
| Daniel S. Lorrain - Officer | Open-market sale | Class A Common Stock | 100 | $16.00 | $2K | |
| Daniel S. Lorrain - Officer | Option exercise | Stock Option (right to buy) | 100 | $0.00 | - | |
| Carmine N. Stengone - Officer | Option exercise | Class A Common Stock | 400 | $1.26 | $504 | |
| Carmine N. Stengone - Officer | Open-market sale | Class A Common Stock | 400 | $16.00 | $6K | |
| Carmine N. Stengone - Officer | Option exercise | Stock Option (right to buy) | 400 | $0.00 | - | |
| Daniel S. Lorrain - Officer | Option exercise | Class A Common Stock | 400 | $1.01 | $404 | |
| Daniel S. Lorrain - Officer | Open-market sale | Class A Common Stock | 400 | $16.00 | $6K | |
| Daniel S. Lorrain - Officer | Option exercise | Stock Option (right to buy) | 400 | $0.00 | - | |
| Daniel S. Lorrain - Officer | Open-market sale | Class A Common Stock | 3,000 | $14.82 footnote F2 | $44K | |
| Daniel S. Lorrain - Officer | Open-market sale | Class A Common Stock | 1,170 | $15.25 footnote F3 | $18K | |
| ||||||
| John Stephen Healy - Officer | Grant or award | Stock Option (right to buy) | 206,411 | $0.00 | - | |
| Peter T. Slover - Officer | Grant or award | Stock Option (right to buy) | 192,000 | $0.00 | - | |
| Carmine N. Stengone - Officer | Grant or award | Stock Option (right to buy) | 445,000 | $0.00 | - | |
| Daniel S. Lorrain - Officer | Grant or award | Stock Option (right to buy) | 160,000 | $0.00 | - | |
| Daniel S. Lorrain - Officer | Grant or award | Stock Option (right to buy) | 6,500 | $0.00 | - | |
| Tim Watkins - Officer | Option exercise | Class A Common Stock | 3,611 | $4.50 | $16K | |
| Tim Watkins - Officer | Open-market sale | Class A Common Stock | 2,800 | $14.09 footnote F2 | $39K | |
| Tim Watkins - Officer | Open-market sale | Class A Common Stock | 811 | $14.48 footnote F3 | $12K | |
| Tim Watkins - Officer | Option exercise | Stock Option (right to buy) | 3,611 | $0.00 | - | |
| Tim Watkins - Officer | Grant or award | Stock Option (right to buy) | 160,000 | $0.00 | - | |
| ||||||
Item 8.01, 9.01
Item 2.02, 9.01
Item 7.01, 9.01
Item 5.07
Recent CTNM Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Daniel Lorrain | Officer | 4,170 | $56K | View on EDGAR | |
| CARMINE STENGONE | Director, Officer | 2,500 |
CTNM insider trading FAQ
What is the latest insider trade for CTNM?
Contineum Therapeutics, Inc. (CTNM) had 2 insider filings in the last 90 days, with the most recent on 2026-09-08. The full record for CTNM runs to 32 Form 4 filings, the earliest from 2024-11-20. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CTNM stock?
No insider purchases of CTNM were filed in the last 90 days.
How many insiders are selling CTNM stock?
2 insider sales of CTNM were filed in the last 90 days, totaling $81K.
Where can I see CTNM SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CTNM Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Carmine N. Stengone view on EDGAR
- - Carmine N. Stengone view on EDGAR
- - Daniel S. Lorrain view on EDGAR
- - Carmine N. Stengone view on EDGAR
- - Daniel S. Lorrain view on EDGAR
- - Tim Watkins view on EDGAR
- - Carmine N. Stengone view on EDGAR
- - Gines Diego Miralles view on EDGAR
- - Lori Lyons-Williams view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where CTNM's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CTNM with a 7-day demo
- CTNM on your watchlist
- Every CTNM Form 4 filing on record
- Up to 3 months of CTNM price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
